Continuous analyte monitoring system

Patent metadata

Field	Value
Publication number	US-11071455-B2
Application number	US-201715810822-A
Country	US
Kind code	B2
Filing date	Nov 13, 2017
Priority date	Dec 31, 2013
Publication date	Jul 27, 2021
Grant date	Jul 27, 2021

Abstract

An improved analyte monitoring system having a sensor and a transceiver with improved communication and/or user interface capabilities. The transceiver may communicate with and power the sensor. The transceiver may receive one or more analyte measurements from the sensor and may calculate one or more analyte concentrations based on the received analyte measurements. The transceiver may generate analyte concentration trends, alerts, and/or alarms based on the calculated analyte concentrations. The system may also include a display device, which may be, for example, a smartphone and may be used to display analyte measurements received from the transceiver. The display device may execute a mobile medical application. The system may include a data management system, which may be web-based.

First claim

What is claimed is:

1. A system for detecting an amount or concentration of an analyte in vivo within a living organism, the system comprising:
(A) an analyte sensor;
(B) an on-body transceiver comprising:
(B1) a sensor interface configured to receive data signals from the analyte sensor;
(B2) a display interface that comprises a wireless communication circuit; and
(B3) a processor configured to:
calculate an analyte concentration based on the received data signals,
generate a signal to initiate a vibratory alert based on the calculated analyte concentration, and
cause the display interface to wirelessly convey analyte information including the calculated analyte concentration and the generated signal to initiate the vibratory alert;

(C) a display device configured to receive the analyte information, vibrate in response to the generated signal to initiate the vibratory alert, and execute a mobile medical application that displays the calculated analyte concentrations; and
(D) adhesive configured to hold the transceiver in place on the body of the living organism.

2. The system of claim 1 , wherein the analyte information conveyed to the display device comprises the received data signals, and the mobile medical application is configured to calculate analyte concentration.

3. The system of claim 1 , wherein the analyte sensor is an implantable sensor.

4. The system of claim 1 , wherein the display device is a smartphone.

5. The system of claim 1 , wherein the wireless communication circuit employs a wireless communication standard to wirelessly convey the calculated analyte concentrations.

6. The system of claim 5 , wherein the wireless communication standard is a Bluetooth standard.

7. The system of claim 1 , wherein the transceiver does not display the calculated analyte concentrations.

8. The system of claim 1 , wherein the display device is configured to upload analyte concentrations to a web-based data management system.

9. The system of claim 8 , further comprising the web-based data management system.

10. The system of claim 1 , wherein the processor of the transceiver is configured to perform an analyte concentration calibration based on one or more user-entered calibration points.

11. The system of claim 10 , wherein the display interface of the transceiver receives the one or more user-entered calibration points from the display device.

12. The system of claim 11 , wherein the display device is configured to facilitate user entry of the calibration points.

13. The system of claim 1 , wherein the processor of the transceiver is further configured to calculate an analyte concentration trend based on the calculated analyte concentration.

14. The system of claim 1 , wherein the analyte sensor comprises:
(A1) an analyte indicator configured to produce a detectable property based on the amount or concentration of the analyte in proximity to the analyte indicator;
(A2) sensor elements configured to generate a data signal based on the detectable property produced by the analyte indicator; and
(A3) a transceiver interface configured convey data signals generated by the sensor elements.

15. The system of claim 14 , wherein the analyte sensor further comprises a sensor housing, and the sensor elements and transceiver interface are contained within the sensor housing.

16. The system of claim 14 , wherein the detectable property is an optical property.

17. The system of claim 14 , wherein the sensor elements comprise a light source and a photodetector.

18. The system of claim 14 , wherein the transceiver interface of the analyte sensor is an antenna configured to wirelessly convey the data signals generated by the sensor elements, and the sensor interface of the transceiver is an antenna configured to wirelessly receive the data signals from the antenna of the analyte sensor.

19. The system of claim 18 , wherein the antennas of the analyte sensor and transceiver are inductive elements.

20. The system of claim 14 , wherein the sensor interface of the transceiver and the transceiver interface of the analyte sensor are a wire connected through a transdermal needle tip.

21. The system of claim 1 , wherein the analyte is glucose.

22. A system for detecting an amount or concentration of an analyte in vivo within a living organism, the system comprising:
(A) an analyte sensor;
(B) an on-body transceiver comprising:
(B1) a sensor interface configured to receive data signals from the analyte sensor;
(B2) a processor configured to:
calculate an analyte concentration based on the received data signals,
calculate an analyte concentration trend based on the calculated analyte concentration, and
generate a signal to initiate a vibratory alert based on the calculated analyte concentration and the calculated analyte concentration trend; and

(B3) a display interface configured to convey analyte information;

(C) a display device configured to receive the analyte information and execute a mobile medical application that displays analyte concentrations;
(D) adhesive configured to hold the transceiver in place on the body of the living organism; and
(E) a vibration motor configured to vibrate in response to the generated signal to initiate the vibratory alert.

23. The system of claim 22 , wherein the analyte information conveyed to the display device comprises the calculated analyte concentration.

24. The system of claim 22 , wherein the display interface of the transceiver comprises a wireless communication circuit configured to wirelessly convey the analyte information.

25. The system of claim 24 , wherein the conveyed analyte information includes the calculated analyte concentration and the generated signal to initiate the vibratory alert.

26. The system of claim 22 , wherein the conveyed analyte information includes the generated signal to initiate the vibratory alert, and the display device comprises the vibration motor that is configured to vibrate in response to the generated signal to initiate the vibratory alert.

27. The system of claim 22 , wherein the on-body transceiver comprises the vibration motor that is configured to vibrate in response to the generated signal to initiate the vibratory alert.

28. A system for detecting an amount or concentration of an analyte in vivo within a living organism, the system comprising:
(A) an analyte sensor;
(B) an on-body transceiver comprising:
(B1) a sensor interface configured to receive data signals from the analyte sensor;
(B2) a processor configured to:
calculate an analyte concentration based on the received data signals, and
generate a signal to initiate a vibratory alert based on the calculated analyte concentration;

(B3) a display interface configured to convey analyte information; and
(B4) a notification device including a vibration motor, and the transceiver is configured to use the generated signal to initiate the vibratory alert to control the notification device to generate a vibrational signal;

(C) a display device configured to receive the analyte information and execute a mobile medical application that displays analyte concentrations; and
(D) adhesive configured to hold the transceiver in place on the body of the living organism.

Assignees

• Senseonics Inc

Inventors

• Dehennis Andrew
• Raisoni Barkha
• Whitehurst Todd

Classifications

• A61B5/0022 Primary

  Monitoring a patient using a global network, e.g. telephone networks, internet · CPC title

• A61B5/002

  Monitoring the patient using a local or closed circuit, e.g. in a room or building (A61B5/0017 takes precedence) · CPC title

• A61B5/14532

  for measuring glucose, e.g. by tissue impedance measurement · CPC title

• A61B5/7275

  Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor · CPC title

• A61B5/7455

  characterised by tactile indication, e.g. vibration or electrical stimulation · CPC title